GL1X · GenesisL1 explorer

Ligand · 166

166 · 6-carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-yl]-hexanoic acid

166, 6-carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-yl]-hexanoic acid (C22 H26 N2 O4, 382.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…

Component
166
Formula
C22 H26 N2 O4
Class
ligand
Structures
2
PDB entries
1

Binding sites

166 in 2 structures; the first of them:

  • 1QJ1 · Novel Covalent Active Site Thrombin Inhibitors · 166 B1248 · binds CYS42, HIS57, TYR60A, TRP60D, LYS60F, LEU99, TRP148, ILE174 and 15 more
  • 1QJ1 · Novel covalent active site thrombin inhibitors · 166 B1248 · binds CYS42, HIS57, TYR60A, TRP60D, LYS60F, LEU99, TRP148, ILE174 and 15 more

Residues it binds most

GLY 2, CYS 2, TRP 2, ASP 2, GLU 2, SER 2, ALA 2, HIS 2, ILE 2, LEU 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.